Sympathoadrenal mechanisms in the pathogenesis of sleep apnea-related hypertension

Current Hypertension Reports

Volumn 11, Issue 3, 2009, Pages 212-216

  Friedman, Oded ^b   Logan, Alexander G ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADRENERGIC SYSTEM; CHEMORECEPTOR REFLEX; CONFOUNDING VARIABLE; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOXEMIA; NONHUMAN; OBESITY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRESSORECEPTOR REFLEX; PREVALENCE; REGULATORY MECHANISM; REVIEW; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

ANIMALS; BLOOD PRESSURE; DISEASE PROGRESSION; HUMANS; HYPERTENSION; SLEEP APNEA SYNDROMES; SYMPATHETIC NERVOUS SYSTEM;

EID: 65749104998     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0037-2     Document Type: Review

References (36)

1. Basner RC: Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 2007, 356:1751-1758.
2. Strohl KP, Redline S: Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996, 154:279-289.
3. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328:1230-1235.
4. Ryan CM, Bradley TD: Pathogenesis of obstructive sleep apnea. J Appl Physiol 2005, 99:2440-2450.
5. Nieto FJ, Young TB, Lind BK, et al.: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000, 283:1829-1836.
6. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
7. Bazzano LA, Khan Z, Reynolds K, He J: Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
8. Rahmouni K, Correia ML, Haynes WG, Mark AL: Obesity-associated hypertension: New insights into mechanisms. Hypertension 2005, 45:9-14.
9. Narkiewicz K, van de Borne PJ, Cooley RL, et al.: Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998, 98:772-776.
10. Grassi G, Facchini A, Trevano FQ, et al.: Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 2005, 46:321-325.
11. Leuenberger UA, Brubaker D, Quraishi S, et al.: Effects of intermittent hypoxia on sympathetic activity and blood pressure in humans. Auton Neurosci 2005, 121:87-93.
12. Cutler MJ, Swift NM, Keller DM, et al.: Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol 2004, 96:754-761.
13. Tamisier R, Anand A, Nieto LM, et al.: Arterial pressure and muscle sympathetic nerve activity are increased after two hours of sustained but not cyclic hypoxia in healthy humans. J Appl Physiol 2005, 98:343-349.
14. Gilmartin GS, Tamisier R, Curley M, Weiss JW: Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes following recurrent nocturnal sustained hypoxia in humans. Am J Physiol Heart Circ Physiol 2008, 295:H778-H785.
15. Weiss JW, Liu MD, Huang J: Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol 2007, 92:21-26.
16. Narkiewicz K, van de Borne PJ, Montano N, et al.: Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998, 97:943-945.
17. Cutler MJ, Swift NM, Keller DM, et al.: Periods of intermittent hypoxic apnea can alter chemoreflex control of sympathetic nerve activity in humans. Am J Physiol Heart Circ Physiol 2004, 287:H2054-H2060.
18. Tamisier R, Nieto L, Anand A, et al.: Sustained muscle sympathetic activity after hypercapnic but not hypocapnic hypoxia in normal humans. Respir Physiol Neurobiol 2004, 141:145-155.
19. Cooper VL, Pearson SB, Bowker CM, et al.: Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia-a mechanism for promoting hypertension in obstructive sleep apnoea. J Physiol 2005, 568:677-687.
20. Cooper VL, Bowker CM, Pearson SB, et al.: Effects of simulated obstructive sleep apnoea on the human carotid baroreceptor-vascular resistance reflex. J Physiol 2004, 557:1055-1065.
21. Cooper VL, Elliott MW, Pearson SB, et al.: Daytime variability of baroreflex function in patients with obstructive sleep apnoea: implications for hypertension. Exp Physiol 2007, 92:391-398.
22. Cooper VL, Elliott MW, Pearson SB, et al.: Daytime variability in carotid baroreflex function in healthy human subjects. Clin Auton Res 2007, 17:26-32.
23. Lai CJ, Yang CC, Hsu YY, et al.: Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol 2006, 100:1974-1982.
24. Dematteis M, Julien C, Guillermet C, et al.: Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008, 177:227-235.
25. Fletcher EP: Invited review: physiological consequences of intermittent hypoxia: Systemic blood pressure. J Appl Physiol 2001, 90:1600-1605.
26. Dujic Z, Ivancev V, Heusser K, et al.: Central chemoreflex sensitivity and sympathetic neural outflow in elite breath-hold divers. J Appl Physiol 2008, 104:205-211.
27. Fu Q, Townsend NE, Shiller SM, et al.: Intermittent hypobaric hypoxia exposure does not cause sustained alterations in autonomic control of blood pressure in young athletes. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1977-R1984.
28. Heitmann J, Ehlenz K, Penzel T, et al.: Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004, 23:255-262.
29. Narkiewicz K, Kato M, Phillips BG, et al.: Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332-2335.
30. Mills PJ, Kennedy BP, Loredo JS, et al.: Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006, 100:343-348.
31. Phillips CL, Yang Q, Williams A, et al.: The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007, 16:217-225.
32. Imadojemu VA, Mawji Z, Kunselman A, et al.: Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007, 131:1406-1413.
33. Bonsignore MR, Parati G, Insalaco G, et al.: Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: Effects of acute CPAP. Eur Respir J 2006, 27:128-135.
34. Logan AG, Tkacova R, Perlikowski SM, et al.: Refractory hypertension and sleep apnoea: Effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21:241-247.
35. Noda A, Nakata S, Koike Y, et al.: Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 2007, 30:669-676.
36. Kohler M, Pepperell JC, Casadei B, et al.: CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008, 32:1488-1496.